Viewing Study NCT03430700


Ignite Creation Date: 2025-12-26 @ 12:15 PM
Ignite Modification Date: 2026-02-27 @ 11:58 PM
Study NCT ID: NCT03430700
Status: UNKNOWN
Last Update Posted: 2023-01-30
First Post: 2018-02-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer
Sponsor: University College, London
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Peritoneal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None platinum-resistant View